Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Proponents often emphasize the potential for substantial therapeutic gains, particularly in ailments where conventional medications have proven inadequate. However, crucially important to evaluate the substantial financial burden associated with CPI st